Global Pet DNA Testing Market Size Poised for Significant Growth with 9.21 percent CAGR, Projected to Reach USD 641 Million by 2030
| NEOG Stock | USD 12.04 0.02 0.17% |
Roughly 63% of all Neogen's stockholders are looking to take a long position. The analysis of overall sentiment of trading Neogen stock suggests that some investors are interested at this time. The current market sentiment, together with Neogen's historical and current headlines, can help investors time the market. In addition, many technical investors use Neogen stock news signals to limit their universe of possible portfolio assets.
Neogen |
Exploring the Surging Demand for Pet DNA Testing and its Impact on the Animal Healthcare Industry 214 Pages Research Study According to a market research study published by Zion Market Research, the demand analysis of Global Pet DNA Testing Market size share revenue was valued at around USD 321 Million in 2021 and is estimated to grow about USD 641 Million by 2030, at a CAGR of approximately 9.21 percent between 2022 and 2030. The key market players are listed in the report with their sales, rev
Read at finance.yahoo.com
 |
Neogen Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Neogen can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Neogen Fundamental Analysis
We analyze Neogen's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Neogen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Neogen based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Earnings Per Share
Earnings Per Share Comparative Analysis
Neogen is currently under evaluation in earnings per share category among its peers. Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Neogen Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Neogen stock to make a market-neutral strategy. Peer analysis of Neogen could also be used in its relative valuation, which is a method of valuing Neogen by comparing valuation metrics with similar companies.
Peers
Neogen Related Equities
| XGN | Exagen | 9.34 | ||||
| SERA | Sera Prognostics | 8.00 | ||||
| BNR | Burning Rock | 6.99 | ||||
| IQV | IQVIA Holdings | 3.00 | ||||
| RDNT | RadNet | 1.85 | ||||
| MYGN | Myriad Genetics | 1.44 | ||||
| ICLR | ICON PLC | 1.42 | ||||
| QGEN | Qiagen NV | 0.79 | ||||
| MEDP | Medpace Holdings | 0.64 | ||||
| FONR | Fonar | 0.20 | ||||
| SHC | Sotera Health | 0.23 | ||||
| ACRS | Aclaris Therapeutics | 1.81 |
Complementary Tools for Neogen Stock analysis
When running Neogen's price analysis, check to measure Neogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neogen is operating at the current time. Most of Neogen's value examination focuses on studying past and present price action to predict the probability of Neogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neogen's price. Additionally, you may evaluate how the addition of Neogen to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |